Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
1.975
-0.055 (-2.71%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Stereotaxis Employees
Stereotaxis had 139 employees as of December 31, 2024. The number of employees increased by 17 or 13.93% compared to the previous year.
Employees
139
Change (1Y)
17
Growth (1Y)
13.93%
Revenue / Employee
$193,655
Profits / Employee
-$182,396
Market Cap
169.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
STXS News
- 4 days ago - Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025 - GlobeNewsWire
- 5 days ago - Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025 - GlobeNewsWire
- 5 weeks ago - Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program - GlobeNewsWire
- 6 weeks ago - Stereotaxis to Present at 37th Annual Roth Conference - GlobeNewsWire
- 7 weeks ago - Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn - Seeking Alpha
- 7 weeks ago - Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery - GlobeNewsWire
- 7 weeks ago - Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance - GlobeNewsWire